Joaquim Mullol
Grupo de investigación
- Inmunoalergia respiratoria clínica y experimental (IRCE) Group leader (R4)
Publicaciones destacadas
-
EUFOREA Consensus on Biologics for CRSwNP with or without asthma
Autores:Referencia: Allergy 2019. -
Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons
Autores:Referencia: Molecular Neurobiology 2019. -
Recovery of Olfactory Function After Excitotoxic Lesion of the Olfactory Bulbs Is Associated with Increases in Bulbar SIRT1 and SIRT4 Expressions
Autores:Referencia: Molecular Neurobiology 2019. -
Olfactory training in posttraumatic smell impairment: mild improvement in threshold performances - results from a randomized controlled trial.
Autores:Referencia: Journal Of Neurotrauma 2018. -
Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis.
Autores:Referencia: Journal Of Allergy And Clinical Immunology 2018. -
Nasal obstructive disorders impair health-related quality of life in adolescents with persistent allergic rhinitis: a real-life study.
Autores:Referencia: Pediatric Allergy And Immunology 2017. -
Position paper on olfactory dysfunction
Autores:Referencia: Rhinology. Supplement 2017. -
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial
Autores:Referencia: Jama-Journal Of The American Medical Association 2016. -
Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study)
Autores:Referencia: Bmj Open 2012. -
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists
Autores:Referencia: Rhinology 2012.
Proyectos destacados
-
Papel de los microRNA en la modulación in vitro de la diferenciación mucociliar e inflamación del epitelio nasosinusal en la poliposis nasal
Investigador/a principal: Joaquim Mullol I MiretFinanciador: Fondo de Investigación Sanitaria (FIS) Instituto de Salud Carlos III, Ministerio de Sanidad y ConsumoCódigo: PI18-00469Duración: 01/01/2019 - 31/12/2021 -
Expression of Rupatadine on PAF-induced inflammation in blood eosinophils and epithelial cells from nasal polyps and healthy nasal mucosa (RINOPAF-2 Study).
Investigador/a principal: Joaquim Mullol I MiretFinanciador: URIACH S.ACódigo: RINOPAF-02-2018Duración: 01/01/2019 - 31/12/2021 -
Función reguladora de los microRNA sobre los genes diana involucrados en la diferenciación epitelial de la mucosa nasosinusal en la poliposis nasal.
Investigador/a principal: Joaquim Mullol I MiretFinanciador: Fondo de Investigación Sanitaria (FIS) Instituto de Salud Carlos III, Ministerio de Sanidad y ConsumoCódigo: PI15-00046Duración: 01/01/2016 - 31/12/2019 -
Estudio de los mecanismos por los cuales el Omalizumab es capaz de mejorar el asma persistente asociada a la Enfermedad Respiratoria Exacerbada por AINES (EREA)
Investigador/a principal: Irina BoboleaFinanciador: SEPARCódigo: SEPAR'18Duración: 01/01/2019 - 31/12/2021 -
Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.
Investigador/a principal: Joaquim Mullol I MiretFinanciador: MEDA PharmaCódigo: DYMECOS IIDuración: 01/01/2016 - 31/12/2019